Science journalist
Elie Dolgin, PhD, is a freelance science journalist who specializes in biomedical research and drug discovery.
Elie Dolgin is a science journalist who splits his time between rural Vermont and urban Massachusetts. He holds a bachelor's degree in biology from McGill University and a PhD in evolutionary genetics from the University of Edinburgh. A former news editor at STAT, Nature Medicine and The Scientist, Elie has also written for publications including the New York Times, Newsweek and Science magazine.
His 2021 feature article for Nature, "The tangled history of mRNA vaccines," gained significant recognition and was referenced widely in the scientific literature, in national newspaper stories and by award selection committees.
In The Media
Recent Projects
Language model delivers predictions that rival years of lab work.
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
The Department of Defense is continuing to bankroll projects to develop vaccines against deadly pathogens.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.
AI and real-time neural feedback could transform treatments.